[ad_1]
Newport Beach, California., May 13 2021 /PRNewswire/-Innovative, science-driven pharmaceutical company Vivera Pharmaceuticals, Inc. has been named Farah Al Qaissieh To the Committee of Ambassadors of the Department of Neuroscience. As an ambassador, Ms. Al Qaissieh will play a key role in supporting and guiding Vivera’s focus expansion, starting in her home country-the United States, to provide mental and neurotherapy to patients all over the world. United Arab Emirates.
Ms. Al Qaissieh is an accomplished motivational speaker who founded Stutter UAE in 2013. She co-sponsored the establishment of iStutter Center with SpeechCare Center in the United States, which is an online speech therapy center focusing on stuttering treatment. Portugal. Ms. Al Qaissieh stammered and shared her journey in the short documentary. Just another accent, The function is in Cannes Film Festival Film Festival.
She said: “I am honored to join the ambassador committee of the innovative company Vivera, which places great emphasis on supporting people who stutter.” Farah Al Qaissieh. “As we work to help people learn to celebrate their accents and stutter, I look forward to opening the Bay Area to Vivira.”
Ms. Al Qaissieh is an active member of Arab youth leaders, a leader and a respected role model in her community. In 2018, Ms. Al Qaissieh won the Abu Dhabi Award, which is the highest civilian medal in the UAE, and was recognized by the Emirate of the UAE. Abu DhabiIn recognition of her positive impact on the community.
The vice president and co-founder of Vivera Pharmaceuticals said: “We are delighted to introduce Ms. Al Qaissieh as a neuroscience ambassador.” Olivia Karpinski. “With her valuable guidance, we can focus the neuroscience department’s work on the areas that have the greatest impact on patients both domestically and globally.”
“We welcome Ms. Al Qaissieh to join our committee of neuroscience ambassadors,” said the doctor. Stephen McColgan, Chief Medical Officer of Vivera Pharmaceuticals. “We not only need more young advocates to take up public roles, but also more young women. Ms. Al Qaissieh’s work and popularity are very important to the fluency-disabled community.”
Vivera is committed to researching and developing treatments for various neurological diseases to improve the lives of patients and providers. Vivera’s neuroscience department is currently using the company’s TABMELT® technology to develop novel neuropsychiatric therapies, which is a patented sublingual drug delivery system for drug use.
About Vivera Pharmaceuticals
Founded in 2018, Vivera is a disruptive pharmaceutical company dedicated to the development of new therapies for various indications, including opioid deterrence and withdrawal, non-addiction solutions for pain management, and pharmaceutical and medical Equipment products. The company is composed of six departments, each with a unique task that works together to support Vivera’s core task of putting patients first.
For more information, please visit www.viverapharmaceuticals.com Or contact us LinkedIn, Facebook, Twitter or Instagram.
contact: Megan Kay
megan@cerrell.com
814-574-8011
View original content to download multimedia:http://www.prnewswire.com/news-releases/vivera-pharmaceuticals-welcomes-farah-al-qaissieh-as-neurosciences-ambassador-301291159.html
Source: Vivera Pharmaceuticals, Inc.
[ad_2]
Source link
